Common non-epigenetic drugs as epigenetic modulators

Area of Science:

• Pharmacology
• Epigenetics
• Drug Discovery

Background:

• Growing evidence suggests common medications can induce epigenetic alterations.
• These changes involve modifications to DNA methylation and histone conformations.
• Drug interactions with epigenetic enzymes and DNA repair mechanisms are implicated.

Purpose of the Study:

• To investigate the potential of common drugs to induce epigenetic modifications.
• To highlight the role of epigenetic alterations in drug effects and resistance.
• To underscore the need for advanced epigenetic screening tools.

Main Methods:

• Review of existing evidence on drug-induced epigenetic effects.
• Computational prediction of drug interactions with histone deacetylase (HDAC).
• Experimental verification of predicted HDAC interactions.

Main Results:

• Common drugs (opioids, cannabinoids, valproic acid, cytostatics) can alter epigenetic patterns.
• Computational analysis predicted significant potential for drug interaction with HDAC.
• Experimental validation confirmed HDAC interaction for a high-probability compound.
• Epigenetic effects contribute to drug efficacy, toxicity, and resistance.

Conclusions:

• Drug-induced epigenetic modifications are a significant factor in pharmacology.
• Epigenetic alterations can lead to diverse phenotypes and influence drug resistance.
• There is an urgent need for cost-effective epigenetic screening tools due to potential heritability.